ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,813,000 | -76.8% | 39,589 | -83.1% | 0.40% | -76.2% |
| Q2 2021 | $29,319,000 | +21.1% | 233,638 | +30.9% | 1.69% | +16.1% |
| Q1 2021 | $24,212,000 | +415.8% | 178,538 | +386.6% | 1.46% | +421.9% |
| Q4 2020 | $4,694,000 | -29.9% | 36,688 | -38.4% | 0.28% | -43.9% |
| Q3 2020 | $6,700,000 | -67.6% | 59,546 | -72.6% | 0.50% | -61.9% |
| Q2 2020 | $20,710,000 | +39.5% | 217,390 | +31.6% | 1.31% | -4.9% |
| Q1 2020 | $14,843,000 | +90.4% | 165,160 | +12.3% | 1.37% | +144.3% |
| Q4 2019 | $7,796,000 | -51.7% | 147,032 | -64.0% | 0.56% | -61.5% |
| Q3 2019 | $16,130,000 | +62.9% | 408,262 | +69.4% | 1.46% | +60.2% |
| Q2 2019 | $9,902,000 | – | 241,043 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |